Researchers in the UK are beginning an important clinical trial of a relatively new type of weight loss, or bariatric, surgery. The minimally invasive procedure is designed to reduce the production of the so-called “hunger hormone” called ghrelin, but with less cost and upkeep than existing bariatric treatments.…
